Financial Performance - The company's revenue for Q3 2025 reached ¥98,157,774.87, representing a year-on-year increase of 16.56%[4] - Net profit attributable to shareholders was ¥2,642,736.91, up 13.01% compared to the same period last year[4] - The net profit excluding non-recurring gains and losses was ¥2,455,643.54, an increase of 30.60% year-on-year[4] - Total operating revenue for the period reached ¥293,435,063.47, an increase of 6.0% compared to ¥276,782,336.74 in the previous period[20] - The net profit for the current period is 11,028,066.24, a decrease of 3.81% compared to 11,464,131.61 in the previous period[22] - The operating profit for the current period is 11,793,963.23, slightly up from 11,558,231.41 in the previous period, indicating a growth of 2.03%[21] - The total revenue from operating activities is 204,148,886.07, compared to 207,481,201.00 in the previous period, reflecting a decrease of 1.12%[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥677,804,210.10, a decrease of 0.82% from the end of the previous year[4] - Total assets as of September 30, 2025, were ¥677,804,210.10, down from ¥683,376,139.16, a decrease of 0.8%[16] - Total liabilities decreased to ¥44,048,193.72 from ¥56,829,790.22, a reduction of 22.5%[18] - The company's equity attributable to shareholders increased to ¥633,756,016.38 from ¥626,546,348.94, an increase of 1.9%[18] Cash Flow - The company's cash flow from operating activities showed a net outflow of ¥12,633,661.71, which is a 7.63% increase in outflow compared to the previous year[4] - The cash flow from operating activities shows a net outflow of -12,633,661.71, an improvement from -13,676,896.91 in the previous period[24] - The cash and cash equivalents decreased to ¥187,813,817.72 from ¥207,539,725.16, a decline of 9.0%[16] - The cash and cash equivalents at the end of the period stand at 187,813,817.72, a decrease from 190,791,850.56 in the previous period[25] - The total cash outflow from investing activities is -2,030,874.81, significantly less than -30,054,364.16 in the previous period, showing a reduction in cash outflow[25] Expenses - The company reported a 49.77% increase in financial expenses compared to the same period last year, primarily due to a decrease in interest income[9] - Research and development expenses increased to 12,173,824.16, up from 11,448,783.65, marking a rise of 6.35%[21] - The total tax expenses for the current period are 756,686.17, a significant increase from 30,982.85 in the previous period[21] - The financial expenses have improved, showing a net income of -1,997,390.37 compared to -3,976,393.57 in the previous period[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 5,273[12] - The company has released a total of 34,700 restricted shares during the period, reducing the total restricted shares to 104,100[14] Future Plans - The company plans to focus on expanding its market presence and developing new products in the upcoming quarters[19] Other Financial Metrics - The weighted average return on equity was 0.42%, an increase of 0.05% from the previous year[4] - Accounts receivable increased significantly to ¥96,903,197.03, compared to ¥77,312,665.91, marking a growth of 25.5%[17] - Inventory decreased slightly to ¥123,682,047.14 from ¥130,521,823.31, a reduction of 5.2%[17] - The basic and diluted earnings per share are both 0.1242, down from 0.1291 in the previous period, indicating a decline of 3.73%[22] - The company experienced a 257.37% increase in asset disposal income compared to the previous year, attributed to gains from the disposal of idle assets[10] - Contract liabilities increased by 41.17% compared to the beginning of the year, mainly due to an increase in advance payments received[9]

Financial Performance - Q3 2025 revenue was CNY 86,895,992.45, a decrease of 1.93% year-over-year, while year-to-date revenue reached CNY 251,952,110.33, an increase of 5.66%[5] - Net profit attributable to shareholders for Q3 2025 was CNY 15,563,787.73, down 13.03% year-over-year, with year-to-date net profit at CNY 44,734,363.57, a decrease of 3.09%[5] - The basic earnings per share for Q3 2025 was CNY 0.07, reflecting a decline of 12.50% compared to the same period last year[5] - Total operating revenue for the current period reached ¥251,952,110.33, an increase of 5.3% compared to ¥238,456,918.22 in the previous period[30] - Net profit for the current period was ¥44,605,407.31, a decrease of 3.0% from ¥46,043,556.04 in the previous period[31] - The basic earnings per share for the current period was ¥0.20, compared to ¥0.21 in the previous period[31] Assets and Liabilities - Total assets at the end of Q3 2025 were CNY 1,154,075,702.53, down 3.91% from the end of the previous year[5] - The company's total assets decreased to ¥1,154,075,702.53 from ¥1,201,093,602.64, representing a decline of 3.9%[29] - The total liabilities remained relatively stable at ¥155,163,511.28, slightly down from ¥155,178,080.65[29] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 7,316,963.44 year-to-date, a significant decrease of 133.31% compared to the previous year[10] - The company's cash flow from operating activities was ¥166,324,951.96, down from ¥232,573,284.38, indicating a decrease of 28.5%[33] - Net cash flow from operating activities decreased to -$7.32 million from $21.96 million year-over-year[34] - The ending balance of cash and cash equivalents decreased to $116.46 million from $264.67 million[35] Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,657[12] - Liu Jun holds 64.49% of shares, totaling 140,848,210 shares[12] - The top 10 shareholders account for a significant portion of the company's equity, with the largest shareholder holding over 64%[12] Investments and Financial Products - The company has a total of 50,159.52 million RMB in entrusted financial products, with 41,579.52 million RMB remaining unexpired[18] - The company has invested 23,659.52 million RMB in bank financial products from self-owned funds, with a remaining balance of 16,879.52 million RMB[18] - The company has various financial products with expected annualized returns ranging from 1.50% to 3.30%[20] - The company has engaged in multiple financial products, including trust and broker financial products, with a total investment of 50,159.52 million RMB[18] Changes in Financial Position - The company reported a significant decrease in cash and cash equivalents, with a balance of ¥116,691,250.10 as of September 30, 2025, down from ¥274,877,982.53 at the beginning of the period, representing a decline of approximately 57.5%[26] - Accounts receivable increased by 32.32% to CNY 186,433,073.08, attributed to sales not yet collected during the reporting period[8] - The company reported a decrease in accounts payable to ¥107,780,415.52 from ¥90,359,186.82, an increase of 19.3%[28] Research and Development - Research and development expenses increased to ¥16,757,569.48 from ¥14,176,551.71, marking a growth of 18.2%[30] New Financial Strategies - The company approved a restricted stock incentive plan on July 7, 2025, granting 950,000 shares at a price of ¥8.55 per share to 33 eligible participants[24] - The company plans to implement a new structured deposit product with a floating return of 1.2%-2% and a total amount of ¥1,200,000, set to mature between August and December 2025[23] - The company is actively pursuing new funding strategies, including the issuance of structured deposits with varying interest rates to attract more capital[23]

陕西华达科技股份有限公司 2025 年第三季度报告 证券代码：301517 证券简称：陕西华达 公告编号：2025-041 陕西华达科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 公司是否需追溯调整或重述以前年度会计数据 □是 ☑否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入（元） | 176,439,810.22 | 11.05% | 430,428,805.90 | -11.77% | | 归属于上市公司股东 | -418,435.95 | -104.4 ...

2025 年第三季度报告 北京大北农科技集团股份有限公司 1 北京大北农科技集团股份有限公司 2025 年第三季度报告 证券代码：002385 证券简称：大北农 公告编号：2025-088 北京大北农科技集团股份有限公司 2025 年第三季度报告 2.公司负责人邵根伙、主管会计工作负责人姜晗及会计机构负责人(会计主管人员)张欣声明：保证季度报告中财务信息的 真实、准确、完整。 3.第三季度财务会计报告是否经过审计 □是 否 2 北京大北农科技集团股份有限公司 2025 年第三季度报告 一、主要财务数据 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | 项目 | 本报告期 | 本报告期比上年 | 年初至报告 | | | --- | --- | --- | --- | --- | | | | 同期增减 | 年初至报告期末 ...

仲景食品股份有限公司 2025 年第三季度报告 证券代码：300908 证券简称：仲景食品 公告编号：2025-043 2、公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度 报告中财务信息的真实、准确、完整。 重要内容提示： 1、董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 3、第三季度财务会计报告是否经过审计 □是 √否 仲景食品股份有限公司 一、主要财务数据 （一） 主要会计数据和财务指标 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 公司是否需追溯调整或重述以前年度会计数据 □是 √否 | | 本报告期 | 本报告期比上年 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 同期增减 | | 比上年同期增减 | | 营业收入（元） | 301,081,398.59 | 0.11% ...

Financial Performance - The company's revenue for Q3 2025 was ¥62,587,665.89, representing a decrease of 41.00% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2025 was ¥6,299,213.74, down 72.33% year-on-year[5] - The basic earnings per share for Q3 2025 was ¥0.09, a decline of 73.53% compared to the previous year[5] - Total operating revenue for the current period is CNY 209,425,876.45, a decrease from CNY 293,304,171.94 in the previous period[25] - Net profit for the current period is CNY 33,110,619.12, compared to CNY 77,797,479.73 in the previous period, reflecting a significant decline[26] - Total comprehensive income for the period was CNY 33,110,619.12, a decrease from CNY 77,797,479.73 in the previous period[27] - Basic and diluted earnings per share were both CNY 0.5, down from CNY 1.17 in the previous period[27] Assets and Liabilities - Total assets at the end of Q3 2025 were ¥1,591,158,509.46, a decrease of 0.79% from the end of the previous year[5] - The company's total assets are CNY 1,591,158,509.46, slightly down from CNY 1,603,808,014.06 in the previous period[22] - Total liabilities decreased to CNY 78,392,417.50 from CNY 90,439,507.46 in the previous period[22] - The total equity attributable to shareholders of the parent company is CNY 1,512,766,091.96, slightly down from CNY 1,513,368,506.60 in the previous period[22] Cash Flow - The net cash flow from operating activities for the first nine months of 2025 was ¥6,359,396.46, down 80.68% year-on-year[12] - Net cash flow from operating activities was CNY 6,359,396.46, significantly lower than CNY 32,913,587.68 in the previous period[29] - Cash inflow from investment activities totaled CNY 1,245,687,125.20, compared to CNY 586,466,383.06 in the previous period[29] - Net cash flow from investment activities was negative at CNY -90,419,418.20, worsening from CNY -81,981,512.08 in the previous period[29] - Cash and cash equivalents at the end of the period were CNY 60,946,286.70, down from CNY 173,284,439.23 at the end of the previous period[29] - Cash outflow from financing activities was CNY 34,288,127.13, compared to CNY 31,144,610.88 in the previous period[29] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,086[14] - The largest shareholder, Tao Chunlei, holds 39.64% of shares, totaling 26,427,800 shares[14] - The second-largest shareholder, Xu Xinluo, holds 14.59% of shares, totaling 9,726,200 shares[14] - The company has a total of 44,593,250 restricted shares at the end of the period, with 349,575 shares released during the period[18] - The company has no preferred shareholders or changes in restricted shares for the reporting period[16] Operational Metrics - The company's inventory decreased by 50.85% to ¥963,381.38 compared to the beginning of the period, primarily due to consumption of raw materials[9] - The company expanded its sales team, resulting in a 30.45% increase in sales expenses to ¥5,623,066.89 for the first nine months of 2025[10] - Investment income for the first nine months of 2025 increased by 289.79% to ¥7,945,781.97, attributed to the disposal of trading financial assets[11] - The company reported a significant increase of 1634.15% in construction in progress, reaching ¥28,888,304.53, due to investments in the second phase of its project[9] Other Financial Information - The company received government subsidies amounting to ¥1,877,237.73 in Q3 2025, contributing to a total of ¥4,747,212.35 for the year-to-date[6] - Cash and cash equivalents decreased from 179,294,435.57 yuan to 60,946,286.70 yuan, a decline of approximately 66.0%[20] - Trading financial assets increased from 1,023,470,174.93 yuan to 1,100,794,578.30 yuan, an increase of about 7.5%[20] - Accounts receivable decreased from 63,892,072.37 yuan to 60,526,491.01 yuan, a decline of approximately 5.0%[20] - Prepayments increased from 9,942,873.55 yuan to 11,502,053.99 yuan, an increase of about 15.7%[20] - Other receivables increased from 3,990,203.95 yuan to 7,034,124.89 yuan, an increase of approximately 76.5%[20] - Research and development expenses for the current period are CNY 36,961,787.88, down from CNY 43,048,445.44 in the previous period[26] - The company reported a decrease in accounts payable to CNY 32,247,801.97 from CNY 37,833,222.06 in the previous period[22] - Deferred income tax liabilities decreased to CNY 5,688,721.91 from CNY 8,310,227.58 in the previous period[22] - The third quarter financial report was not audited[30]

江苏诺泰澳赛诺生物制药股份有限公司 2025 年第三季度报告 证券代码：688076 证券简称：ST 诺泰 江苏诺泰澳赛诺生物制药股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 478,903,968.66 | 13. ...

威胜信息技术股份有限公司 2025 年第三季度报告 证券代码：688100 证券简称：威胜信息 威胜信息技术股份有限公司 2025 年第三季度报告 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 744,033,280.52 | 3.54 | 2,111,980,975.34 | 8.80 | | 利润总额 | 197,916,769.30 | 10.95 | 553,854,665.21 | 11.45 | | 归属于上市公司股东的 净利润 | 169,087,453.21 | 12.24 | 474,188,191.17 | 12.24 | | 归属于上市公司股东的 扣除非经常性损益的净 利润 | 165,979,924.59 | 13.66 | 464,129,395.28 | 13.02 | | 经营活动产生的现金流 | 不适 ...

上海行动教育科技股份有限公司 2025 年第三季度报告 证券代码：605098 证券简称：行动教育 上海行动教育科技股份有限公司 2025 年第三季度报告 上海行动教育科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、 完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人李践、主管会计工作负责人陈纪红及会计机构负责人（会计主管人员）徐 天怡保证季度报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 （一）主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上 年同期增减变 | 年初至报告期末 | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | | | 增减变动幅度 | | | | 动幅度(%) | | | | | | | | (% ...

江苏集萃药康生物科技股份有限公司 2025 年第三季度报告 证券代码：688046 证券简称：药康生物 江苏集萃药康生物科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 1 / 13 单位：元 币种：人民币 项目 本报告期 本报告期 比上年同 期增减变 动幅度(%) 年初至报告期 末 年初至报告期 末比上年同期 增减变动幅度 (%) 营业收入 200,767,829.39 18.56 575,576,818.48 12.92 利润总额 42,718,585.10 96.06 120,160,805.79 21.13 归属于上市公司股东的 ...